• Noriyasu Ozaki, Yoshihide Nakamura, Tsugutoshi Suzuki, Jun Yoshimoto, Keiko Toyohara, Hitoo Fukuhara, Hiroshi Katayama, Kanta Kishi, Yutaka Odanaka, and Hiroshi Tamai.
• The Department of Pediatrics, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka, 569-0801, Japan. ped069@osaka-med.ac.jp.
• Pediatr Cardiol. 2018 Feb 1; 39 (2): 384-389.

AbstractAn increasing number of children are undergoing radiofrequency catheter ablation (RFCA) for tachyarrhythmia. However, infants and toddlers undergoing RFCA are often resistant to medication or need to eliminate arrhythmia substrate, and the risks of RFCA complications are still high in infants and toddlers. From April 2008 and December 2016, 285 children who underwent radiofrequency catheter ablation (RFCA) were stratified according to body weight (group A, less than 10 kg, n = 22; group B, over 10 kg, n = 263) and the clinical features of RFCA were retrospectively reviewed in these groups. Indications for RFCA included drug-refractory tachyarrhythmia or symptomatic tachycardia and tachycardia-induced cardiomyopathy. The acute success rate in this group was 90.9%, with a relatively low recurrence rate (15.0%) after 7.0 ± 1.6 years follow-up. We performed RFCA using only 2-4 catheters in all cases. Major complications included complete right bundle branch block in one patient. No significant differences in rates of success, recurrence, or complications were noted between children weighing less and more than 10 kg. RFCA is safe and efficacious for tachyarrhythmia even in patients weighing less than 10 kg.

26 keywords...

hide…